Cortés-Vicente et al.14reported that double-SNMG (for MuSK-Abs and AChR-Abs) MG subjects were similar to those with AChR-Abs MG in terms of clinical characteristics and response to treatment. The gene discussed is MUSK; the disease is myasthenia gravis.